Chief Executive Officer and Co-Founder, NanoSyrinx
Joe Healey is the CEO and Co-Founder of NanoSyrinx, a discovery-stage synthetic biology biotech which is developing a novel delivery modality for complex biologics.
Joe founded the company, along with his PhD supervisor Dr Nick Waterfield and a fellow post-doc, Dr Alexia Hapeshi, during his PhD at the University of Warwick’s Medical School, and has been the entrepreneurial lead driving the development of the company from its inception. Joe’s passion has always been synthetic biology, and being able to translate NanoSyrinx’s unusual IP is something of a dream come true. The company is leveraging naturally occurring, genetically encoded ‘nanosyringes’ which are capable of delivering proteins and peptides directly to the cytosol of targeted cells, and the company is looking at applications across therapeutics and cell and gene engineering.
He holds a PhD and MSc in Mathematical Biology and Biophysical Chemistry from the University of Warwick, and graduated top of his class from his BSc (Hons) Biology degree.